Role of Asymmetric Dimethylarginine (ADMA) in Diabetic Vascular Complications

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|14|25|2613-2618

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.14, Iss.25, 2008-09, pp. : 2613-2618

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Asymmetric Dimethylarginine (ADMA) and Leptin in Hypertensive Patients

By Atamer A   Ilhan N   Kocyigit Y   Toprak G   Ozbay M   Celik Y  

The Journal of International Medical Research, Vol. 36, Iss. 1, 2008-01 ,pp. : 54-62

Field House Publishing

Access to resources Recommend Favorite

The synthesis and metabolism of asymmetric dimethylarginine (ADMA)

By Leiper James   Vallance Patrick  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. : 33-38

Springer Publishing Company

Access to resources Recommend Favorite

Asymmetric dimethylarginine (ADMA): an endogenous inhibitor of angiogenesis

By Cooke John  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. : 115-121

Springer Publishing Company

Access to resources Recommend Favorite

Effects of asymmetric dimethylarginine (ADMA) infusion in humans

By Kielstein Jan   Tsikas Dimitrios   Fliser Danilo  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 1, 2006-02 ,pp. : 39-44

Springer Publishing Company

Access to resources Recommend Favorite

Asymmetric Dimethylarginine (ADMA): A Promising Biomarker for Cardiovascular Disease?

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 2, 2013-01 ,pp. : 180-200

Bentham Science Publishers

Access to resources Recommend Favorite